Artigo de periodico

A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study) (2016)

• Authors:
  • Gómez, Henry L.
  • Neciosup, Silvia
  • Tosello, Célia
  • Mano, Max
  • Bines, José
  • Ismael, Gustavo
  • Santi, Patrícia X.
  • Pinczowski, Hélio
  • Nerón, Yeni
  • Fanelli, Marcello
  • Fein, Luis
  • Sampaio, Carlos
  • Lerzo, Guillermo
  • Capó, Adolfo
  • Zarba, Juan J.
  • Blajman, César
  • Varela, Mirta S.
  • Martínez-Mesa, Jeovany
  • Werutsky, Gustavo
  • Barrios, Carlos H.
• Autor USP: MANO, MAX SENNA - FM
• Unidade: FM
• DOI: 10.1016/j.clbc.2015.10.005
• Subjects: SEGUIMENTOS; NEOPLASIAS MAMÁRIAS; METÁSTASE NEOPLÁSICA; ANTINEOPLÁSICOS
• Language: Inglês
• Imprenta:
  • Publisher place: Dallas
  • Date published: 2016
• Source:
  • Título: Clinical Breast Cancer
  • ISSN: 1526-8209
  • Volume/Número/Paginação/Ano: v. 16, n. 1, p. 38-44, 2016

Informações sobre o DOI: 10.1016/j.clbc.2015.10.005 (Fonte: oaDOI API)
• Este periódico é de assinatura
• Este artigo é de acesso aberto
• URL de acesso aberto
• Cor do Acesso Aberto: hybrid
• Licença: cc-by-nc-nd

---

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  GÓMEZ, Henry L. et al. A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study). Clinical Breast Cancer, v. 16, n. 1, p. 38-44, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.clbc.2015.10.005. Acesso em: 09 jan. 2026.

• APA

  Gómez, H. L., Neciosup, S., Tosello, C., Mano, M., Bines, J., Ismael, G., et al. (2016). A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study). Clinical Breast Cancer, 16( 1), 38-44. doi:10.1016/j.clbc.2015.10.005

• NLM

  Gómez HL, Neciosup S, Tosello C, Mano M, Bines J, Ismael G, Santi PX, Pinczowski H, Nerón Y, Fanelli M, Fein L, Sampaio C, Lerzo G, Capó A, Zarba JJ, Blajman C, Varela MS, Martínez-Mesa J, Werutsky G, Barrios CH. A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study) [Internet]. Clinical Breast Cancer. 2016 ; 16( 1): 38-44.[citado 2026 jan. 09 ] Available from: https://doi.org/10.1016/j.clbc.2015.10.005

• Vancouver

  Gómez HL, Neciosup S, Tosello C, Mano M, Bines J, Ismael G, Santi PX, Pinczowski H, Nerón Y, Fanelli M, Fein L, Sampaio C, Lerzo G, Capó A, Zarba JJ, Blajman C, Varela MS, Martínez-Mesa J, Werutsky G, Barrios CH. A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study) [Internet]. Clinical Breast Cancer. 2016 ; 16( 1): 38-44.[citado 2026 jan. 09 ] Available from: https://doi.org/10.1016/j.clbc.2015.10.005

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• Multidisciplinary international survey of post-operative radiation therapy practices after nipple-sparing or skin-sparing mastectomy
• O uso do Oncotype DX® na indicação de quimioterapia adjuvante - experiência do Hospital Sírio-Libanês
• Pneumonite não-infecciosa em paciente com tumor neuroendócrino tratado com everolimus (EVR)
• Return to work after breast cancer diagnosis: An observational prospective study of 125 patients in South America
• Phase 3, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and paclitaxel as first-line therapy in women with HER2+ advanced breast cancer: BOLERO-1
• HER2-targeted therapy in breast cancer: A systematic review of neoadjuvant trials
• Reply to [Carta]: mastectomy skin flap thickness
• Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial
• Value of systemic staging in asymptomatic early breast cancer
• Ascite quilosa em paciente com carcinoma ductal invasivo de mama